Effect of Selective Inhibition of the Inducible Cyclooxygenase on Renin Release in Healthy Volunteers

Vane JR . Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature [New Biology] 1971;231:232–5.

Smith JB , Willis AL . Aspirin selectively inhibits prostaglandin production in human platelets. Nature [New Biology] 1971;231:235–7.

Whorton AR , Smigel M , Oates JA , Frölich JC . Regional differences in prostaglandin formation by the kidney: prostacyclin is a major prostaglandin of renal cortex. Biochim Biophys Acta 1978;529:176–180.

Frölich JC , Stichtenoth DO . NSAID: can renal side effects be avoided? In: Vane JR , Botting JH , Botting RM , eds. Improved non-steroid anti-inflammatory drugs: COX-2 enzyme inhibitors. Dordrecht: Kluwer Academic Publishers 1996:203–28.

Whorton AR , Misono K , Hollifield J , Frölich JC , Inagami T , Oates JA . Prostaglandins and renin release: I. Stimulation of renin release from rabbit renal cortical slices by PGI₂. Prostaglandins 1977;14:1095–104.

Ito S , Carretero OA , Abe K , Beierwaltes WH , Yoshinaga K . Effect of prostanoids on renin release from rabbit isolated afferent arterioles with and without attached macula densa. Kidney Int 1989;35:1138–44.

Xie W , Chipman JG , Robertson DL , Erikson RL , Simmons DL . Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci USA 1991;88:2692–6.

Kujubu DA , Fletcher BS , Varnum CR , Lim W , Herschman H . TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem 1991;266:12866–72.

Vane JR , Botting RM . New insights into the mode of action of anti-inflammatory drugs. Inflamm Res 1995;44:1–9.

Frölich JC . Prostaglandin endoperoxide synthetase isoenzymes: the clinical relevance of selective inhibition. Ann Rheum Dis 1995;54:942–3.

Vane JR . Towards a better aspirin. Nature 1994;367:215–6.

Churchill L , Graham AC , Shih CK . Selective inhibition of human cyclooxygenase-2 by meloxicam. Inflammopharmacology 1996; 4:125–35.

Frölich JC . A classification of NSAIDs according to the relative inhibition of cyclooxygenase isoenzymes. Trends Pharmacol Sci 1997;18:30–4.

Stichtenoth DO , Wagner B , Frölich JC . Effects of meloxicam and indomethacin on cyclooxygenase pathways in healthy volunteers. J Invest Med 1997;45:44–9.

Funk CD , Funk LB , Kennedy ME , Pong AS , Fitzgerald GA . Human platelet/erythroleukemia cell prostaglandin G/H synthase: CDNA cloning, expression, and gene chromosomal assignment. FASEB J 1991;5:2304–12.

Patrono C , Wennmalm A , Ciabattoni G , Nowak J , Pugliese F , Cinotti GA . Evidence for an extra-renal origin of urinary prostaglandin E₂ in healthy men. Prostaglandins 1979;16:623–9.

Türck D , Busch U , Heinzel G , Narjes H . Clinical pharmacokinetics of meloxicam. Eur J Rheumatol Inflam 1996;15:23–30.

Reynolds JEF , ed. Martindale, the Extra Pharmacopoeia, 30th edition, London: Pharmaceutical press, 1993:19–21.

Frölich JC , Wilson TW , Sweetman BJ , Smigel M , Nies AS , Carr K , Watson JT , Oates JA . Urinary prostaglandins. Identification and origin. J Clin Invest 1975;55:763–70.

Haber E , Koerner T , Page LB , Kliman B , Purnode A . Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects. J Clin Endocrinol 1969;29:1349–55.

Fauler J , Tsikas D , Mayatepek E , Keppler D , Frölich JC . Impaired degradation of prostaglandins and thromboxane in Zellweger syndrome. Pediatr Res 1994;36:449–55.

Frölich JC , Hollifield JW , Dormois JC , Frölich BL , Seyberth HJ , Michelakis AM , Oates JA . Suppression of plasma renin activity by indomethacin in man. Circ Res 1976;39:447–52.

Walker LA , Frölich JC . Renal prostaglandins and leukotrienes. Rev Physiol Biochem Pharmacol 1987;107:1–71.

Rosenkranz B , Kitajima W , Frölich JC . Relevance of urinary 6-keto-prostaglandin F1a determination. Kidney Int. 1981;19:755–9.

Brunel P , Hornych A , Guyene TT , Sioufi A , Turri M , Ménard J . Renal and endocrine effects of flosulide, after single and repeated administration to healthy volunteers. Eur J Clin Pharmacol 1995;49:193–201.

Vane JR , Botting RM . Overview-mechanisms of action of anti-inflammatory drugs In: Vane JR , Botting JH , Botting RM , eds. Improved non-steroid anti-inflammatory drugs: COX-2 enzyme inhibitors. Dordrecht: Kluwer Academic Publishers 1996:1–27.

Harding P , Sigmon DH , Alfie ME , Huang PL , Fishman MC , Beierwaltes WH , Carretero OA . Cyclooxygenase-2 mediates increased renal renin content induced by low sodium diet. Hypertension 1997;29:297–302.

Pairet M , Churchill L , Engelhardt G . Differential inhibition of cyclooxygenases 1 and 2 by NSAIDs. In: Bazan N , Botting J , Vane J , eds. New targets in inflammation. Inhibitors of COX-2 or adhesion molecules. Dordrecht, Boston, London: Kluwer Academic Publishers, William Harvey Press, 1996:23–38.

Harris RC , McKanna JA , Akai Y , Jacobson HR , DuBois RN , Breyer MD . Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. J Clin Invest 1994;94:2504–2510.

Kömhoff M , Gröne H-J , Klein T , Seyberth HW , Nüsing RM . Localization of cyclooxygenase-1 and 2 in adult and fetal human kidney: implication for renal function. Am J Physiol 1997;272:F460–8.

Ehrich E , Schnitzer T , McIlwain H . MK-966, a highly selective COX-2 inhibitor, is effective in the treatment of osteoarthritis in a 6-week pilot study. Poster No 161. 19th ILAR Congress of Rheumatology, Singapore 1997, 47.

Clive DM , Stoff JS . Renal syndromes associated with nonsteroidal antiinflammatory drugs. N Engl J Med 1984;310:563–72.

Carmichael J , Shankel S . Effects of nonsteroidal anti-inflammatory drugs on prostaglandins and renal function. Am J Med 1985;78:992–1000.

Bevis PJR , Bird HA , Lapham G . An open study to assess the safety and tolerability of meloxicam 15 mg in subjects with rheumatic disease and mild renal impairment. Brit J Rheumatol 1996;35(1 Suppl):56–60.

Degner F . Inhibition of COX-2 and its clinical relevance. Selective COX-2 inhibition, abstracts & posters, 19th ILAR Congress of Rheumatology, Singapore 1997, 31-5.